SCHEMBL15072201

SCHEMBL15072201

O=C(O)c1cn(-c2ccncc2)nc1-c1cccc(Br)c1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.66
KDM4E B2RXH2 4/20 0.66
HPGD P15428 3/20 0.66
L3MBTL1 Q9Y468 3/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
HSD17B10 Q99714 2/20 0.66
KMT2A Q03164 4/20 0.59
MEN1 O00255 3/20 0.59
LMNA P02545 1/20 0.57
MAPT P10636 4/20 0.48
AURKA O14965 1/20 0.48
ATM Q13315 1/20 0.48
NPSR1 Q6W5P4 2/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 2/20 0.46
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15072200 0.86 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL15079443 0.86 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL15076914 0.85 ALDH1A1 (0.89) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL15072197 0.85 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL15072162 0.84 ALDH1A1 (0.72) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL15070383 0.82 ALDH1A1 (0.88) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL15070211 0.81 ALDH1A1 (0.71) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL6681044 0.80 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL15072193 0.78 ALDH1A1 (0.74) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2
SCHEMBL15072199 0.77 ALDH1A1 (0.65) ALDH1A1KDM4EHPGDL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013096630-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 WO disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed
US-20130165464-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165464-A1 HETEROARYLS AND USES THEREOF PIK3C2B, PI4KB, PIK3R4 ALDH1A1 2884/4885KDM4E 1614/4885HPGD 4133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.